Pfizer Inc (PFE)
28.58
+0.24
(+0.85%)
USD |
NYSE |
Oct 04, 16:00
28.62
+0.04
(+0.14%)
Pre-Market: 20:00
Pfizer Shareholders Equity (Annual): 89.01B for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 89.01B |
| December 31, 2022 | 95.66B |
| December 31, 2021 | 77.20B |
| December 31, 2020 | 63.24B |
| December 31, 2019 | 63.14B |
| December 31, 2018 | 63.41B |
| December 31, 2017 | 71.31B |
| December 31, 2016 | 59.54B |
| December 31, 2015 | 64.72B |
| December 31, 2014 | 71.30B |
| December 31, 2013 | 76.31B |
| December 31, 2012 | 81.26B |
| December 31, 2011 | 82.19B |
| December 31, 2010 | 87.81B |
| December 31, 2009 | 90.01B |
| December 31, 2008 | 57.56B |
| December 31, 2007 | 65.01B |
| December 31, 2006 | 71.36B |
| December 31, 2005 | 65.76B |
| December 31, 2004 | 68.28B |
| Date | Value |
|---|---|
| December 31, 2003 | 65.38B |
| December 31, 2002 | 19.95B |
| December 31, 2001 | 18.29B |
| December 31, 2000 | 16.08B |
| December 31, 1999 | 13.95B |
| December 31, 1998 | 8.81B |
| December 31, 1997 | 7.933B |
| December 31, 1996 | 6.954B |
| December 31, 1995 | 5.507B |
| December 31, 1994 | 4.324B |
| December 31, 1993 | 3.866B |
| December 31, 1992 | 4.719B |
| December 31, 1991 | 5.026B |
| December 31, 1990 | 5.092B |
| December 31, 1989 | 4.536B |
| December 31, 1988 | 4.301B |
| December 31, 1987 | 3.882B |
| December 31, 1986 | 3.415B |
| December 31, 1985 | 2.927B |
| December 31, 1984 | 2.484B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
63.14B
Minimum
2019
95.66B
Maximum
2022
77.65B
Average
77.20B
Median
2021
Shareholders Equity (Annual) Benchmarks
| Amgen Inc | 6.232B |
| Gilead Sciences Inc | 22.83B |
| Johnson & Johnson | 68.77B |
| Eli Lilly and Co | 10.77B |
| Moderna Inc | 13.85B |